Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Eptifibatide cost effective for acute coronary disorders

    • 7 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Eptifibatide cost effective for acute coronary disorders. Pharmacoecon. Outcomes News 351, 9 (2002). https://doi.org/10.1007/BF03278734

    Download citation

    Keywords

    • Placebo
    • Myocardial Infarction
    • Percutaneous Coronary Intervention
    • Acute Coronary Syndrome
    • Coronary Artery Bypass Graft